Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038379 (
strabismus
)
9,317
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Drosophila CREB-binding protein (dCBP) is a very large multidomain protein, which belongs to the
CBP
/p300 family of proteins that were first identified by their ability to bind the CREB transcription factor and the adenoviral protein E1. Since then
CBP
has been shown to bind to >100 additional proteins and functions in a multitude of different developmental contexts. Among other activities,
CBP
is known to influence development by remodeling chromatin, by serving as a transcriptional coactivator, and by interacting with terminal members of several signaling transduction cascades. Reductions in
CBP
activity are the underlying cause of Rubinstein-Taybi syndrome, which is, in part, characterized by several eye defects, including
strabismus
, cataracts, juvenile glaucoma, and coloboma of the eyelid, iris, and lens. Development of the Drosophila melanogaster compound eye is also inhibited in flies that are mutant for
CBP
. However, the vast array of putative protein interactions and the wide-ranging roles played by
CBP
within a single tissue such as the retina can often complicate the analysis of
CBP
loss-of-function mutants. Through a series of genetic screens we have identified several genes that could either serve as downstream transcriptional targets or encode for potential
CBP
-binding partners and whose association with eye development has hitherto been unknown. The identification of these new components may provide new insight into the roles that
CBP
plays in retinal development. Of particular interest is the identification that the CREB transcription factor appears to function with
CBP
at multiple stages of retinal development.
...
PMID:A genetic screen identifies putative targets and binding partners of CREB-binding protein in the developing Drosophila eye. 1599 17
The Rubinstein-Taybi syndrome (RTS) is a rare but well-defined condition characterized by growth and mental retardation, broad thumb-hallux, and distinctive facial features. Ten unrelated Taiwanese children (6 boys and 4 girls) with clinical features suggestive of RTS were evaluated. The associated anomalies included cryptochidism (6/6 males), microcephaly (9/10), congenital heart diseases (8/10), pectus excavatum (5/10), low IGF-I level (4/10),
strabismus
/nystagmus (4/10), epilepsy (3/10), glaucoma (2/10), cleft palate (2/10), web neck (2/10), limb hypoplasia (2/10), sleep apnea (1/10), and vesico-ureteral reflux (1/10). All of them had normal thyroid function. High-resolution chromosome studies by both G- and R-banding were applied to detect any microscopic chromosomal deletion, particularly over the 16p13 region (responsible for RTS locus). A panel of five cosmids spanning the human cyclic AMP-responsive element binding (CREB) binding protein (CREBBP or
CBP
) gene in terms of RT100, RT102, RT191, RT203 and RT166 (Leiden, the Netherlands) were used for fluorescence in situ hybridization on the metaphases of those patients. Three cases showed whole or partial deletion of one copy of the
CBP
gene. Thus, the rate for detecting interstitial submicroscopic deletion of this region by FISH was about 30% in these RTS patients. The disease severity seemed to be correlated with size of the deletion.
...
PMID:Rubinstein-Taybi syndrome: clinical and molecular cytogenetic studies. 1623 61